PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.43%
Revenue growth under 50% of 2127.T's 19.68%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-1.29%
Negative gross profit growth while 2127.T is at 16.86%. Joel Greenblatt would examine cost competitiveness or demand decline.
1.44%
EBIT growth below 50% of 2127.T's 23.65%. Michael Burry would suspect deeper competitive or cost structure issues.
-18.28%
Negative operating income growth while 2127.T is at 23.10%. Joel Greenblatt would press for urgent turnaround measures.
5.98%
Net income growth under 50% of 2127.T's 31.75%. Michael Burry would suspect the firm is falling well behind a key competitor.
5.99%
EPS growth under 50% of 2127.T's 31.79%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
5.99%
Diluted EPS growth under 50% of 2127.T's 31.79%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Share reduction while 2127.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.31%
10Y revenue/share CAGR under 50% of 2127.T's 454.87%. Michael Burry would suspect a lasting competitive disadvantage.
2.26%
5Y revenue/share CAGR under 50% of 2127.T's 369.68%. Michael Burry would suspect a significant competitive gap or product weakness.
-26.41%
Negative 3Y CAGR while 2127.T stands at 158.98%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
10Y OCF/share CAGR in line with 2127.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
100.00%
5Y OCF/share CAGR is similar to 2127.T's 100.00%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
No Data
No Data available this quarter, please select a different quarter.
108.41%
Below 50% of 2127.T's 1708.57%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
54.75%
Below 50% of 2127.T's 960.74%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-17.52%
Negative 3Y CAGR while 2127.T is 328.67%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
63.41%
Below 50% of 2127.T's 192.35%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
33.94%
Below 50% of 2127.T's 166.97%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-10.40%
Negative 3Y equity/share growth while 2127.T is at 95.39%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.52%
Inventory shrinking or stable vs. 2127.T's 22.52%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
6.64%
Similar asset growth to 2127.T's 6.40%. Walter Schloss finds parallel expansions or investment rates.
3.81%
50-75% of 2127.T's 6.09%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
66.15%
Debt growth of 66.15% while 2127.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
3.57%
We expand SG&A while 2127.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.